Cuipeng M. Qiu

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection.

A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection.

Journal: British journal of cancer

Published: September 25, 2024

A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations.

A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations.

Journal: Cancers

Published: July 19, 2023

Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma.

Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma.

Journal: Heliyon

Published: July 06, 2023

Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans.

Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans.

Journal: International journal of molecular sciences

Published: January 09, 2023

Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1.

Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1.

Journal: Molecules (Basel, Switzerland)

Published: December 18, 2022

Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.

Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: November 21, 2022

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.

Journal: Cells

Published: September 01, 2022

Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.

Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.

Journal: Molecular oncology

Published: April 13, 2022

Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients.

Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients.

Journal: Biomedicines

Published: December 15, 2021

Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysis.

Diagnostic value of RNA for hepatocellular carcinoma: a network meta-analysis.

Journal: Biomarkers in medicine

Published: November 16, 2021

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.

Journal: Cancer science

Published: August 25, 2021

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer.

Journal: Frontiers in immunology

Published: April 21, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026